维普期刊资源整合服务平台（V6.5）

384篇 您的检索式：作者名="CALVERLEY PM"

选中清除导出查看参考文献查看引证文献引用追踪共20页首页上一页第1页下一页末页 /20 跳转

	题名	作者	年代	出处	被引量
1	The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide显示文摘	Wedzicha JA Calverley PM Seemungal TA	2008	Am J Respir Crit Care Med2008，177，1：	1
2	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘	Calverley PM Anderson JA Celli B	2007	N Engl J Med2007，356，8：	1
3	Randomised,double blind,placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease:the ISOLDE trial显示文摘	Burge PS Calverley PM Jone PW		0，，：	1
4	Bias due to withdrawal in long - term randomised trials in COPD : evidence from the TORCH study 显示文摘	Vestbo J Anderson JA Calverley PM	2011	Clin Respir J2011，5，1：	1
5	Reported pneumonia in patients with COPD显示文摘	Calverley PM Stockley RA Seemungal TA	2011	CHEST2011，139，3：	1
6	Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study 显示文摘	Ferguson GT Calverley PM Anderson JA	2009	Chest2009，136，6：	1
7	Salmeterol and flutica sone propionate and survival in chronic obstructive pulmonary dis- ease显示文摘	Calverley PM Anderson JA Celli B	2007	N Engl J Med2007，356，77：	1
8	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley PM Anderson JA Celli B	2007	N Engl J Med2007，356，8：	1
9	Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary显示文摘	PAUWEIS RA BUIST AS CALVERLEY PM	2001	AmJ Respir Crit Care Med2001，163，：	1
10	Characterisation of COPD heterogeneity in the ECLIPSE cohort 显示文摘	Agusti A Calverley PM Celli B	2010	Respir Res2010，11，1：	1
11	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators:two randomised clinical trials显示文摘	Fabbri LM Calverley PM Izquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
12	Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary 显示文摘	Pauwels RA Buist AS Calverley PM	2001	Am J Respir Crit Care Med2001，163，5：	1
13	Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GLOD) workship summary显示文摘	Pauwels RA Buist AS Calverley PM	2001	Am J Respir Crit Care Med2001，163，5：	1
14	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with lon- gacting bronchodilators : two randomised clinical trials 显示文摘	Fabbri LM Calverley PM Lzquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
15	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley PM Anderson JA Celli B	2007	N Engl J Med2007，356，8：	1
16	Roflumilast in symptomatic chronic obstructive pulmonary disease:two randomised clinical trials显示文摘	Calverley PM Rabe KF Goehring UM	2009	Lancet2009，374，9691：	1
17	Rofiumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 显示文摘	Calverley PM Rabe KF Goehring UM	2009	Lancet2009，374，9691：	1
18	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials显示文摘	Fabbri LM Calverley PM Izquierdo-Alonso JL	2009	Lancet2009，374，9691：	1
19	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley PM Anderson JA Celli B	2007	N EnglJ Med2007，356，8：	1
20	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	Han MK Agusti A Calverley PM		0，，：	1

返回顶部每页显示：

共20页首页上一页第1页下一页末页 /20 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示